We are live on ! Find out more
AVIR icon

Atea Pharmaceuticals
AVIR

143 hedge funds and large institutions have $477M invested in Atea Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 47 increasing their positions, 35 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 35

11% more call options, than puts

Call options by funds: $15.8M | Put options by funds: $14.2M

2% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 47

1% more funds holding

Funds holding: 142 → 143 (+1)

4.15% less ownership

Funds ownership: 68.67% → 64.52% (-4.2%)

76% less capital invested

Capital invested by funds: $1.99B → $477M (-$1.52B)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

Holders
143
Holders Change
+1
Holders Change %
+0.7%
% of All Funds
2.2%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
48
Increased
47
Reduced
35
Closed
47
Calls
$15.8M
Puts
$14.2M
Net Calls
+$1.56M
Net Calls Change
+$326K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$83.8M
2
BlackRock
BlackRock
New York
+$25.6M
3
Citadel Advisors
Citadel Advisors
Florida
+$24.5M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$23.8M
5
State Street
State Street
Massachusetts
+$19.1M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$190M
2
PA
Perceptive Advisors
New York
-$79.2M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$58M
4
AIIC
AJU IB Investment Company
South Korea
-$57.4M
5
CAM
Cormorant Asset Management
Massachusetts
-$50.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Man Group
51
Man Group
United Kingdom
$697K -$150K -9,608 -11%
CM
52
Caption Management
Oklahoma
$671K +$1.17M +75,000 New
Deutsche Bank
53
Deutsche Bank
Germany
$654K -$322K -20,692 -22%
PL
54
Parkwood LLC
Ohio
$643K +$1.12M +71,932 New
Macquarie Group
55
Macquarie Group
Australia
$639K +$1.09M +70,000 +4,654%
Wellington Management Group
56
Wellington Management Group
Massachusetts
$635K +$790K +50,716 +249%
Nomura Holdings
57
Nomura Holdings
Japan
$603K +$1.05M +67,346 New
DekaBank Deutsche Girozentrale
58
DekaBank Deutsche Girozentrale
Germany
$546K +$965K +61,900 New
American Century Companies
59
American Century Companies
Missouri
$527K -$143K -9,201 -14%
PAM
60
Panagora Asset Management
Massachusetts
$518K +$903K +57,961 New
Two Sigma Advisers
61
Two Sigma Advisers
New York
$502K +$876K +56,200 New
SEI Investments
62
SEI Investments
Pennsylvania
$483K +$843K +54,079 New
AFM
63
Anson Funds Management
Texas
$477K +$831K +53,340 New
Wells Fargo
64
Wells Fargo
California
$463K -$3.58M -229,956 -82%
TD Asset Management
65
TD Asset Management
Ontario, Canada
$455K -$648K -41,614 -45%
Massachusetts Financial Services
66
Massachusetts Financial Services
Massachusetts
$454K +$792K +50,816 New
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
$439K +$10.1K +649 +1%
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
$416K -$2.93K -188 -0.4%
JP Morgan Chase
69
JP Morgan Chase
New York
$411K +$32.3K +2,070 +5%
Citigroup
70
Citigroup
New York
$366K +$519K +33,318 +436%
Walleye Trading
71
Walleye Trading
New York
$333K +$581K +37,282 New
Swiss National Bank
72
Swiss National Bank
Switzerland
$326K – – –
EGM
73
Engineers Gate Manager
New York
$321K +$560K +35,924 New
AC
74
Aristides Capital
Kentucky
$314K +$547K +35,132 New
AIG
75
American International Group
New York
$307K -$16K -1,027 -3%
1 2
3
4 5

AVIR Hedge Fund Activity: Q4 2021 in Review

143 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Atea Pharmaceuticals (AVIR) for Q4 2021, worth a combined $477M — down 76% from $1.99B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new AVIR positions and 47 closed out — a net gain of 1 holder — while 47 added to existing stakes and 35 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $83.8M. The largest seller was RA Capital Management, exiting entirely with an estimated $190M sold.

  • 143 institutional investors held Atea Pharmaceuticals (AVIR) as of Q4 2021, up from 142 in Q3 2021.
  • Funds reported $477M of Atea Pharmaceuticals stock for Q4 2021, down 76% quarter-over-quarter.
  • 48 funds opened new Atea Pharmaceuticals positions in Q4 2021 and 47 closed out, a net change of +1 holder.
  • The largest Atea Pharmaceuticals buyer in Q4 2021 was EcoR1 Capital, an estimated $83.8M added.
  • The largest Atea Pharmaceuticals seller in Q4 2021 was RA Capital Management, an estimated $190M sold.

Based on aggregated 13F filings for Q4 2021.